These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 26052694)

  • 1. Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.
    Grage SL; Sani MA; Cheneval O; Henriques ST; Schalck C; Heinzmann R; Mylne JS; Mykhailiuk PK; Afonin S; Komarov IV; Separovic F; Craik DJ; Ulrich AS
    Biophys J; 2017 Feb; 112(4):630-642. PubMed ID: 28256223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning mutagenesis identifies residues that improve the long-term stability and insecticidal activity of cyclotide kalata B1.
    Huang YH; Jiang Z; Du Q; Yap K; Bigot A; Kaas Q; Wang CK; Craik DJ
    J Biol Chem; 2024 Mar; 300(3):105682. PubMed ID: 38272233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-plasmodial and anti-inflammatory activities of cyclotide-rich extract and fraction of
    Nworu CS; Ejikeme TI; Ezike AC; Ndu O; Akunne TC; Onyeto CA; Okpalanduka P; Akah PA
    Afr Health Sci; 2017 Sep; 17(3):827-843. PubMed ID: 29085411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleation of a key beta-turn promotes cyclotide oxidative folding.
    Tian S; de Veer SJ; Durek T; Wang CK; Craik DJ
    J Biol Chem; 2024 Apr; 300(4):107125. PubMed ID: 38432638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics exploration of poration and leaking caused by Kalata B1 in HIV-infected cell membrane compared to host and HIV membranes.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    Sci Rep; 2017 Jun; 7(1):3638. PubMed ID: 28620219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor.
    Sando L; Henriques ST; Foley F; Simonsen SM; Daly NL; Hall KN; Gustafson KR; Aguilar MI; Craik DJ
    Chembiochem; 2011 Nov; 12(16):2456-62. PubMed ID: 21928440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations support a preference of cyclotide kalata B1 for phosphatidylethanolamine phospholipids.
    Roseli RB; Huang YH; Henriques ST; Kaas Q; Craik DJ
    Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184268. PubMed ID: 38191035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine.
    Gran L; Sandberg F; Sletten K
    J Ethnopharmacol; 2000 Jun; 70(3):197-203. PubMed ID: 10837983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.
    Plan MR; Rosengren KJ; Sando L; Daly NL; Craik DJ
    Biopolymers; 2010; 94(5):647-58. PubMed ID: 20564013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic scenario of membrane binding process of kalata b1.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    PLoS One; 2014; 9(12):e114473. PubMed ID: 25473840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of an unusually stable cyclic peptide, kalata B2 from Oldenlandia affinis.
    Nair SS; Romanuka J; Billeter M; Skjeldal L; Emmett MR; Nilsson CL; Marshall AG
    Biochim Biophys Acta; 2006 Oct; 1764(10):1568-76. PubMed ID: 16987719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.
    Plan MR; Göransson U; Clark RJ; Daly NL; Colgrave ML; Craik DJ
    Chembiochem; 2007 Jun; 8(9):1001-11. PubMed ID: 17534989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclotides are a component of the innate defense of Oldenlandia affinis.
    Mylne JS; Wang CK; van der Weerden NL; Craik DJ
    Biopolymers; 2010; 94(5):635-46. PubMed ID: 20564018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Silico Template Selection of In-Vitro Evolved Kalata B1 of Oldenlandia Affinis for Scaffolding Peptide-Based Drug Design.
    Senthilkumar B; Kumar P; Rajasekaran R
    J Cell Biochem; 2016 Jan; 117(1):66-73. PubMed ID: 26052694
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.